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AbstrACt
Objectives Excessive daytime sleepiness (EDS) is 
a common sleep complaint in the population and is 
increasingly recognised as deleterious for health. Simple 
and sensitive tools allowing identifying individuals at 
greater risk of EDS would be of public health importance. 
Hence, we determined trajectories of body silhouette 
from early childhood to adulthood and evaluated their 
association with EDS in adulthood.
Design A retrospective analysis in a prospective 
community-based study.
Participants 6820 men and women self-reported their 
silhouette at ages 8, 15, 25, 35 and 45 using the body 
silhouettes proposed by Stunkard et al. EDS was defined 
by an Epworth Sleepiness Scale score ≥11.
Main outcome measure Presence of EDS in adulthood.
results The study population comprised 6820 
participants (mean age 59.8 years, 61.1% men). Five 
distinct body silhouettes trajectories over the lifespan 
were identified: 31.9% ‘lean stable’, 11.1% ‘lean increase’, 
16.1% ‘lean-marked increase’, 32.5% ‘moderate stable’ 
and 8.4% ‘heavy stable’. Subjects with a ‘heavy-stable’ 
trajectory (OR 1.24, 95% CI 0.94 to 1.62) and those with a 
‘lean-marked increase’ trajectory (OR 1.46, 95% CI 1.18 to 
1.81) were more likely to have EDS when compared with 
the ‘lean-stable’ group after adjusting for confounding. 
Further adjustment for birth weight strengthened the 
magnitude of the ORs.
Conclusion Increasing body silhouette and to a lesser 
extent constantly high body silhouette trajectory from 
childhood to adulthood are associated with increased 
likelihood of EDS, independently of major confounding 
variables.
trial registration number NCT00741728; Pre-results.
IntrODuCtIOn
Excessive daytime sleepiness (EDS) is highly 
common in the general population. Its prev-
alence has been reported up to 28%,1–4 and 
is expected to rise.5 EDS has been associated 
with an increased risk of occupational 
injuries,6 and in addition with a twofold 
increased risk of cardiovascular morbidity 
and up to 70% increased risk of mortality.7 
However, the determinants of EDS remain 
to be firmly established to consider inter-
ventions that may help preventing EDS. 
Given the epidemic of obesity and over-
weight worldwide,8 establishing a relation-
ship between anthropometric markers 
and EDS would carry major public health 
implications. Associations between waist 
circumference or body mass index (BMI) 
and EDS have been reported in some,9–12 
but not all studies.13 14 One possible expla-
nation for these discrepancies is that most 
previous studies were cross-sectional so that 
they focused on one single measure of these 
anthropometrics markers.9–11 BMI, as well 
as waist circumference, change over the 
lifespan so that correlating changes in body 
weight with future EDS might bring more 
accurate predictive information. Unfor-
tunately, studies with repeated measure-
ments of BMI or waist circumference and 
with information on EDS are scarce. So far, 
strengths and limitations of this study
 ► Large sample size in a community-based study.
 ► We used a new, lifetime approach to estimate the 
evolution of body shape and weight over the lifes-
pan, bringing information beyond one single mea-
sure of adiposity (such as body mass index or waist 
circumference).
 ► Retrospective recall of body silhouettes.
 ► No objective measures of sleep disorders 
(polysomnography).
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only two studies, including one conducted specifically 
in women, evaluated the association between changes 
in BMI across two measures over time and the occur-
rence of EDS.12 15 These two studies considered BMI 
measures in adulthood only but not during infancy and 
adolescence, which represent critical periods regarding 
weight gain and weight attained in adulthood.16 17 
Self-reported body silhouette has been shown to be a 
simple and reliable marker of body shape and weight.18–21 
Recall of body silhouette at different ages correlates with 
objective measures of BMI at the corresponding ages.18 19 
Hence, by combining recall of body silhouettes at different 
ages, it is possible to construct body silhouette trajectories 
over the life course. Accordingly, some recent studies have 
related self-reported body silhouette trajectories over the 
lifespan with different health-related outcomes including 
mortality, type 2 diabetes or cancer.20–23
In this study, we used a trajectory approach to investi-
gate potential relationship between the trajectory of body 
silhouette from early childhood to adulthood and EDS in 
adulthood. In particular, we hypothesised that it is more 
the dynamic than the starting point value of the body 
silhouette that brings predictive information for EDS in 
adulthood.
MAterIAl AnD MethODs
study population
The design and main objectives of the Paris Prospec-
tive Study III have been published previously.24 It is an 
ongoing prospective observational cohort study in which 
10 157 men and women aged 50–75 years were recruited 
between June 2008 and June 2012. The standard health 
check-up included a complete clinical examination, 
coupled with standard biological tests after an overnight 
fast. A self-administered questionnaire provided informa-
tion related to professional activity, lifestyle, personal and 
family medical history, current health status, and use of 
medications. Our study complies with the Declaration of 
Helsinki. All procedures performed in this study involving 
human participants were in accordance with the ethical 
standards of the institutional research committee and 
with the Declaration of Helsinki 1964 and its later amend-
ments or comparable ethical standards. All the volunteers 
were recruited after signing an informed consent form.
sleep variables
Excessive daytime sleepiness
Participants filled the Epworth Sleepiness Scale (ESS), 
which is a self-administered questionnaire containing 
eight questions evaluating the probability of dozing 
during daily activities, each question being rated from 0 
(would never doze) to 3 (high chance of dozing), so that 
the ESS score ranges from 0 to 24. In accordance with the 
literature, we considered an ESS score of 11 and above to 
define EDS in main analysis.1 25 An ESS score ≥16 was also 
considered to define severe EDS in sensitivity analysis (see 
end of "Statistical analyses" paragraph).
Sleep duration, snoring and sleep-related medications
Sleep pattern was obtained by questionnaire, such as usual 
sleeping and waking times. Information on the frequency 
(never, rarely, regularly or often) of loud snoring during 
night was obtained and we considered ‘regularly or often’ 
snorers versus others. Working schedules were recorded 
(day or night working). A medical doctor checked current 
medication during a face-to-face interview with the study 
participants. WHO Anatomical Therapeutic Chemical 
(ATC) classification was used to categorise medications; 
in particular, sleep-related medications (ie, that may 
impact on sleep) were identified by ATC code N05.
Proxy for sleep-disordered breathing
In the absence of objective sleep-disordered breathing 
(SDB) measures, we constructed a proxy for SDB. A 
participant was considered having a plausible SDB when 
he/she had loud snoring and a cluster of male sex 
and/or BMI >30 kg/m2and/or age 55 or older and/or 
hypertension.
body silhouette assessment
We used body silhouettes adapted from those proposed 
by Stunkard et al.26 At study recruitment, participants 
were asked to recall and choose one body silhouette 
among seven proposed for ages 8, 15, 25, 35 and 45 years. 
Body silhouettes were presented using children and adult 
silhouettes (figure 1).
Covariates
Depression score was assessed using the 13-item Ques-
tionnaire of Depression second version, Abridged 
(QD2A).27 Depressive status (yes/no) was defined by 
a QD2A score ≥7. Prevalent cardiovascular disease, 
including history of stroke, myocardial infarction or 
angina pectoris, was self-reported. Diabetes was defined 
either by the intake of diabetes therapy or a fasting 
blood glucose >7 mmol/L. Blood pressure was measured 
after 10 min of rest in a subject in decubitus. Hyperten-
sive status was defined either by the intake of antihyper-
tensive treatment or a systolic blood pressure ≥140 mm 
Hg or a diastolic blood pressure ≥90 mm Hg. Habitual 
physical activity was assessed using the Baecke’s score.28 
A higher score corresponds to higher physical activity. 
Subjects were also asked to report if their birth weight was 
below 2.5 kg, between 2.5 and 4 kg or above 4 kg. Since 
collecting data about ethnicity is forbidden by law in 
France, ethnicity was assessed from the participant’s and 
the parents’ country of birth.29 We, therefore, considered 
Caucasian, African and non-Caucasian non-African.
statistical analyses
To construct body silhouette trajectories, we selected 
subjects who reported their body silhouettes for at least 
three age periods among the five, including necessarily 
the earliest and the latest period. Since body silhouettes 
across the lifespan are longitudinal data, we used a group-
based trajectory modelling implemented by SAS Proc 
Traj.30 We identified five body silhouette trajectories, 
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based on the change in the Bayesian information crite-
rion (figure 2). Then, we calculated the posterior prob-
ability for each participant to belong to each of the five 
trajectories and attributed the participant to a trajectory 
according to the highest probability. The average prob-
abilities for each group were 86%, 89%, 79%, 89% and 
91%, indicating a good allocation of subjects among 
trajectories. Analysis was initially performed by sex, but 
trajectories were almost identical between men and 
women, and there was no significant interaction between 
sex and group-based trajectories (p value for interac-
tion=0.62). Similarly, there was no significant interaction 
between body silhouette trajectories and age at inclu-
sion (p=0.83). Hence, body silhouettes trajectories were 
described without stratification by gender or age.
The reliability of the obtained trajectories was further 
tested using the kml package of R software. This method 
is based on an implementation of the k-means clustering 
algorithm adapted for longitudinal data.31 According to 
quality criteria (Calinski and Harabasz, Ray and Turi and 
Davies and Bouldin),31 the optimal number of trajecto-
ries was five. Using this approach, we found very similar 
body silhouette trajectories as the previous ones (online 
supplementary figure 1).
Multivariable logistic regression modelling was then 
used to quantify the relationship between body silhou-
ette trajectory and EDS, estimating OR and 95% CIs. To 
be more specific regarding the body silhouette trajec-
tories assignment, we repeated the main analyses after 
considering only subjects with a posterior probability of 
belonging to one trajectory group ≥80%.
To investigate the robustness of the results, we 
conducted several sensitivity analyses. To account to the 
fact that BMI at study recruitment may partly influence 
the body silhouette trajectory, we adjusted the previous 
multivariable model on BMI at study recruitment, 
keeping in mind that overadjustment may be present. 
Furthermore, to test whether early life factors such as 
birthweight impact future body shape, we additionally 
adjusted our analysis for birthweight categories (missing 
in 851 participants), as exact birth weight was not avail-
able. To minimise residual confounding by SDB, we then 
adjusted the model on loud snoring and then on the 
presence of a plausible SDB (missing in 538 subjects). To 
account for missing covariates, we reran the main analysis 
after using multiple imputations by chained equation.32 
Finally, to test for an association with the severity of EDS, 
we considered moderate EDS (ESS between 11 and 14) 
and severe EDS (ESS ≥16), and performed multinomial 
logistic regression.
All analyses were two sided and we considered a 
p<0.05 as statistically significant. Statistical analyses were 
performed with R V.3.1.3 (www. r- project. org) and SAS 
V.9.3.
results
study population
Body silhouette trajectory could be assessed in 7106 
participants, of whom 6820 also had non-missing EDS. 
The study sample comprised 61.1% of men and the mean 
age was 59.8 years (SD 6.3 years). A total of 1154 partici-
pants (16.9%) had EDS, 16.4% in women and 17.0% in 
men, respectively. The rates of EDS decreased with age, 
being 19.3% before 60, 14% before 70% and 13.4% after 
70 (p for trend <0.001).
Anthropometric markers at study recruitment and eDs
As shown in online supplementary table 1, in multivari-
able analysis, EDS was associated with obesity (OR 1.53, 
95% CI 1.21 to 1.94), but not with overweight at study 
recruitment. Furthermore, in multivariable analysis, 
higher waist circumference was significantly associated 
with EDS (OR 1.01 per 1 cm increase, 95% CI 1.00 to 
1.02). However, the association did not reach statistical 
significance when considering clinical cut-off values 
Figure 1 Body silhouettes in (A) children and (B) adults, 
adapted from Stunkard et al.26
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of >88 cm (35 inches) for women and >102 cm (40 inches) 
for men (OR 1.16, 95% CI 0.96 to 1.40).
Age-specific silhouettes and eDs
Table 1 summarises the associations between body silhou-
ette at each age (8, 15, 25, 35 and 45 years) and EDS, 
after adjusting for sex and age at inclusion. Only early 
and extreme body silhouettes were associated with EDS. 
Accordingly, we found strong and significant associations 
between EDS and the heaviest silhouette at age 8 (OR 
2.59, 95% CI 1.14 to 5.54). There was also a moderate 
association between EDS and very lean body silhouette at 
age 8 (OR 1.30, 95% CI 1.03 to 1.64).
body silhouette trajectories analysis
Main analyses
From group-based trajectory modelling, five different 
trajectories were identified (figure 2): 31.9% were clas-
sified as ‘lean stable’, 11.1% as ‘lean increase’, 16.1% as 
‘lean-marked increase’, 32.5% as ‘moderate stable’ and 
8.4% as ‘heavy stable’. Characteristics of participants 
according to body silhouette trajectories are presented 
in table 2. In particular, ‘lean-marked increased’ and 
‘heavy-stable’ trajectories exhibited the highest rates of 
EDS, loud snoring, SDB (proxy) and depression. They 
also had the highest mean BMI values compared with the 
remaining trajectories. Noteworthy, the proportion of 
babies born above 4 kg increased across the five trajecto-
ries (p for trend <0.001).
In multivariable logistic regression (table 3) and 
compared with the ‘lean-stable’ trajectory, two trajectories 
demonstrated an association with EDS: the ‘heavy-stable’ 
trajectory (OR 1.24, 95% CI 0.94 to 1.62) and the ‘lean-
marked increase’ trajectory (OR 1.46, 95% CI 1.18 to 1.81). 
In these analyses, subjects with depressive symptoms and 
short time sleepers (<6 hours vs 6–8 hours) were two times 
more likely to have EDS whereas ageing was related to a 
3% less likelihood of EDS per 1-year increase (table 3). 
When focusing on subjects with a posterior probability of 
belonging to a group trajectory ≥80%, associations with 
‘heavy stable’ (OR 1.52, 95% CI 1.12 to 2.04) and ‘lean-
marked increase’ trajectory (OR 1.77, 95% CI 1.34 to 
2.32) were even higher (online supplementary table 2).
sensitivity analyses
The results of the sensitivity analyses are reported on online 
supplementary table 3. Overall, ORs were consistent with 
those from the main analysis after successively adjusting for 
BMI categories, loud snoring and a proxy for SDB, and after 
performing multiple imputations of missing covariates. 
Further adjustment for birthweight categories strength-
ened the magnitude of the ORs. Of note, in these analyses, 
neither BMI (except BMI ≥30 kg/m2) nor birthweight cate-
gories were related to EDS, whereas loud snoring and SDB 
showed significant associations.
Of the 1154 participants with EDS, 953 had moderate 
EDS and 201 severe EDS. In multinomial logistic regres-
sion, the ‘lean-marked increase’ trajectory was associated 
with moderate EDS (OR 1.47, 95% CI 1.17 to 1.85) and 
to a lesser extent with severe EDS (OR 1.41, 95% CI 0.87 
to 2.26). The ‘heavy-stable’ trajectory was associated with 
moderate EDS (OR 1.27, 95% CI 0.95 to 1.70) but not 
with severe EDS (OR 1.06, 95% CI 0.57 to 2.00).
DIsCussIOn
In this large community-based study, five body silhou-
ette trajectories were identified using self-reported body 
Figure 2 Trajectories of body silhouette. Note: percentages represent the proportion of the population according to each 
trajectory.
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silhouettes at different ages from childhood to adult-
hood. The trajectories were categorised as ‘lean stable’, 
‘lean increase’, ‘lean-marked increase’, ‘moderate stable’ 
and ‘heavy stable’. Compared with subjects with a ‘lean-
stable’ trajectory, those with a ‘lean-marked increase’ and 
‘heavy-stable’ trajectories were the most likely to have 
EDS after accounting for several confounding factors.
In our study, separate analysis of body silhouette for each 
age indicates that extreme and early life body silhouettes 
were associated with EDS in adulthood. This was particu-
larly true for the heavy body silhouette at 8 years of age, 
for which a 2.6-fold increased risk of EDS was observed. 
This may indicate that obesity during childhood is associ-
ated with sleep disorders in children,33 and plays a role in 
sleep disorders during adulthood. However, these figures 
should be interpreted with caution given the small size of 
this subgroup and the width of the 95% CI. On the other 
hand, this association is probably underestimated consid-
ering that the prevalence of obese children is currently 
growing and the fact that our population was born in the 
first part and in the middle of the 20th century.34
Data regarding the association of repeated assess-
ment of adiposity with EDS are scarce. To date, only 
three studies have evaluated the association between 
changes in BMI and occurrence of EDS.12 15 In 1395 
middle-aged subjects from the Penn State Adult cohort, 
an association was found between weight gain 7.5 years 
apart and incident and persistent EDS, whereas weight 
loss was associated with EDS remission.12 The second 
study by Theorell-Haglöw et al also reported an associa-
tion between weight gain 10 years apart and EDS in 4322 
women.15 Lastly, in 1468 adults men and women from 
the Sleep Heart Health Study, every 10 kg gain measured 
5 years apart was associated with a 0.55 point increase 
in the ESS score for women, whereas no association 
was reported in men.35 In these three studies, however, 
change in BMI was based on two repeated measures only; 
also, the three studies were conducted in adults only, so 
that trends in adiposity during infancy and adolescence 
were not available. Taken together, the results of these 
three studies may not give the full spectrum of change in 
BMI over the lifespan. In addition, only one study used a 
standardised and validated questionnaire to define EDS,35 
while another one was conducted selectively in women.15
To the best of our knowledge, this is the first study asso-
ciating body silhouette trajectories from childhood to 
adulthood with future EDS in adulthood. Two body silhou-
ette trajectories were associated with EDS in adulthood. 
Our results on the ‘lean-marked increase’ trajectory are 
consistent with previous studies reporting that children 
Table 1 Excessive daytime sleepiness (EDS) according to body silhouette in men and women at different age from childhood 
to adulthood
Body silhouette
A B C D E F G
8 years
  No of 
EDS/N total (%) 138/780 (18.6) 252/1596 (16.6) 346/2187 (16.39)
239/1568 
(15.8) 125/713 (18.0) 44/232 (19.3) 10/30 (34.5)
  OR (95% CI) 1.30
(1.03 to 1.64)
1.08
(0.89 to 1.31)
1.04
(0.86 to 1.24)
1 (ref) 1.18
(0.93 to 1.49)
1.26
(0.87 to 1.79)
2.59
(1.14 to 5.54)
15 years
  No of 
EDS/N total (%)
51/315 (17.5) 189/1168 (17.1) 385/2309 (17.2) 290/1873 
(16.0)
165/976 (17.4) 48/272 (18.2) 7/28 (25.9)
  OR (95% CI) 1.21
(0.86 to 1.66)
1.10
(0.90 to 1.35)
1.09
(0.92 to 1.29)
1 (ref) 1.12
(0.90 to 1.38)
1.16
(0.82 to 1.62)
1.96
(0.76 to 4.49)
25 years
  No of 
EDS/N total (%)
41/220 (27.5) 231/1394 (24.5) 420/2745 (22.7) 326/2017 
(23.3)
112/580 (27.7) 15/93 (21.8) 0/2 (0)
  OR (95% CI) 1.31
(0.90 to 1.87)
1.08
(0.89 to 1.29)
0.94
(0.80 to 1.11)
1 (ref) 1.25
(0.98 to 1.59)
1.01
(0.55 to 1.74)
Na
35 years
  No of 
EDS/N total (%)
7/65 (11.3) 124/847 (15.6) 382/2453 (16.1) 432/2605 
(17.2)
165/923 (18.5) 39/170 (23.5) 3/11 (27.3)
  OR (95% CI) 0.68
(0.28 to 1.40)
0.92
(0.74 to 1.14)
0.94
(0.81 to 1.09)
1 (ref) 1.09
(0.89 to 1.33)
1.43
(0.97 to 2.06)
1.76
(0.38 to 6.17)
45 years
  No of 
EDS/N total (%)
4/35 (11.8) 62/470 (14.1) 241/1674 (14.9) 422/2665 
(16.4)
316/1728 (19.0) 94/480 (20.5) 15/54 (28.3)
  OR (95% CI) 0.74
(0.22 to 1.90)
0.87
(0.64 to 1.15)
0.91
(0.76 to 1.08)
1 (ref) 1.17
(0.99 to 1.38)
1.26
(0.98 to 1.62)
1.78
(0.94 to 3.21)
 All ORs are adjusted for sex and age at inclusion.
 Na, not applicable due to zero observation; Ref, reference category. 
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Table 2 characteristics of participants according to body silhouette trajectories
Body silhouette trajectory
Lean stable
n=2269 
(31.9%)
Lean increase
n=790 (11.1%)
Lean-marked 
increase
n=1147 (16.1%)
Moderate stable
n=2306 (32.5%)
Heavy stable
n=594 (8.4%) P values
Male sex, n (%) 1414 (62.3) 570 (72.2) 852 (74.3) 1249 (54.2) 281 (47.3) <0.001
Age, mean±SD 59.6±6.03 60.5±6.35 59.3±6.24 59.6±6.25 58.9±5.99 <0.001
Alcohol consumption, 
n (%)
– – – – – <0.001
  Never 229 (10.2) 73 (9.4) 125 (11.0) 239 (10.5) 65 (11.0) – 
  1–2 drinks a day 1724 (76.8) 586 (75.1) 828 (72.5) 1772 (77.5) 477 (80.5) – 
  ≥3 drinks a day 292 (13.0) 121 (15.5) 188 (16.5) 275 (12.0) 50 (8.5) – 
Education level, n (%) – – – – – <0.001
  No graduation 56 (2.5) 30 (3.9) 68 (6.0) 66 (2.9) 21 (3.6) – 
  Under HSD 469 (20.9) 181 (23.2) 307 (26.9) 492 (21.5) 160 (27.0) – 
  ≥HSD 1715 (76.6) 569 (72.9) 765 (67.1) 1732 (75.6) 411 (69.4) – 
Depression, n (%) 79 (3.5) 35 (4.4) 59 (5.15) 102 (4.4) 48 (8.1) <0.001
Living alone, n (%) 565 (25.0) 179 (22.7) 245 (21.4) 584 (25.4) 170 (28.7) 0.007
Baecke’s score, 
mean±SD
6.32±1.45 6.21±1.43 6.19±1.44 6.29±1.43 6.28±1.54 0.13
Diabetes, n (%) 39 (1.7) 34 (4.3) 74 (6.5) 75 (3.3) 22 (3.7) <0.001
Hypertension, n (%) 655 (29.1) 290 (37.1) 458 (40.1) 805 (35.2) 218 (36.9) <0.001
EDS, n (%) 336 (15.4) 123 (16.4) 231 (21.1) 351 (15.7) 113 (19.6) 0.001
Prevalent CVD, n (%) 30 (1.3) 20 (2.5) 29 (2.5) 50 (2.2) 10 (1.7) 0.07
BMI, mean±SD 23.7±2.99 24.1±3.13 26.8±3.51 25.3+3.50 27.9±4.49 <0.001
Birth weight, n (%) – – – – – <0.001
  <2.5 kg 104 (5.4) 58 (9.3) 64 (6.8) 79 (4.0) 21 (4.2) – 
  2.5–4 kg 1683 (86.8) 524 (84.0) 791 (84.3) 1688 (85.8) 401 (80.0) – 
  >4 kg 151 (7.8) 42 (6.7) 83 (8.9) 201 (10.2) 79 (15.8) – 
Waist circumference 
(cm), mean±SD
83.4±10.8 85.7±10.3 91.7±11.0 85.9±11.8 90.6±13.8 <0.001
Sleep-related 
medications, n (%)
79 (4.1) 32 (4.8) 53 (5.3) 90 (4.5) 26 (4.8) 0.67
Night working, n (%) 33 (1.5) 16 (2.0) 21 (1.8) 29 (1.3) 8 (1.4) 0.50
Sleep duration (hours), 
n (%)
– – – – – 0.097
  6–9 hours/night 1913 (87.6) 639 (85.5) 921 (83.4) 1911 (86.8) 476 (85.3) – 
  <6 hours/night 244 (11.2) 97 (13.0) 167 (15.1) 262 (11.9) 77 (13.8) – 
  ≥9 hours/night 28 (1.3) 11 (1.5) 16 (1.5) 28 (1.3) 5 (0.9) – 
Loud snoring, n (%) 667 (31.4) 237 (32.3) 469 (42.8) 686 (32.0) 223 (40.0) <0.001
Proxy for SDB, n (%) 648 (30.5) 229 (31.2) 452 (41.3) 652 (30.4) 210 (37.7) <0.001
Proxy for ethnicity, n 
(%)
– – – – – <0.001
  Caucasian 1966 (88.2) 641 (83.2) 922 (81.3) 1989 (87.5) 509 (87.4) – 
  African 195 (8.7) 99 (12.9) 176 (15.5) 221 (9.7) 57 (9.8) – 
  Non-Caucasian, non-
African
69 (3.1) 30 (3.9) 36 (3.2) 64 (2.8) 16 (2.8) – 
BMI, body mass index; CVD, cardiovascular disease; EDS, excessive daytime sleepiness; HSD, high school diploma; SDB, sleep-disordered 
breathing.
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with a low birth weight and gaining weight rapidly until 
adolescence had a higher risk of medical conditions in 
adulthood, such as diabetes and coronary events.36 37 
Hence, our study identified EDS as a novel detrimental 
consequence of such trajectory.The association of EDS 
with the ‘heavy-stable’ body silhouette trajectory, espe-
cially when investigating subjects with a posterior proba-
bility of belonging to one trajectory group ≥80%, suggests 
that both the magnitude and the duration of excess 
weight may play a role in the development of EDS. This is 
consistent with previous studies showing that duration of 
excess weight and obesity was related to the risk of meta-
bolic complications.38 Furthermore, the ‘heavy-stable’ 
trajectory may identify obesity with a strong genetic 
component that often develops early in life.39 40
In our study, the associations between ‘lean-marked 
increase’ and ‘heavy-stable’ body silhouette trajectories 
and EDS might reflect associations with either the last 
body silhouette measured at age 45 or the BMI at study 
recruitment. However, no association was found between 
Table 3 OR of body silhouettes trajectories for excessive daytime sleepiness
Model 1
OR (95% CI)
Model 2
OR (95% CI)
Model 3
OR (95% CI)
Model 4
OR (95% CI)
Trajectory – – – – 
  Lean stable 1 (ref) 1 (ref) 1 (ref) 1 (ref)
  Lean increase 1.12 (0.89 to 1.41) 1.09 (0.86 to 1.36) 1.06 (0.84 to 1.34) 1.06 (0.81 to 1.37)
  Lean-marked increase 1.46 (1.21 to 1.76) 1.41 (1.16 to 1.69) 1.39 (1.15 to 1.68) 1.46 (1.18 to 1.81)
  Moderate stable 1.02 (0.87 to 1.21) 1.02 (0.87 to 1.21) 1.03 (0.87 to 1.21) 1.00 (0.83 to 1.21)
  Heavy stable 1.30 (1.02 to 1.64) 1.26 (0.99 to 1.59) 1.25 (0.98 to 1.60) 1.24 (0.94 to 1.62)
Age (per 1-year 
increase)
0.96 (0.95 to 0.97) 0.96 (0.95 to 0.97) 0.96 (0.95 to 0.97) 0.96 (0.95 to 0.98)
Male sex 0.97 (0.85 to 1.11) 1.04 (0.91 to 1.19) 1.06 (0.92 to 1.22) 0.98 (0.83 to 1.16)
Depression – 2.27 (1.76 to 2.91) 2.03 (1.55 to 2.63) 2.15 (1.59 to 2.89)
Sleep duration – – – – 
  6–9 hours/night – – 1 (ref) 1 (ref)
  <6 hours/night – – 2.11 (1.77 to 2.50) 2.11 (1.73 to 2.55)
  ≥9 hours/night – – 0.70 (0.48 to 0.98) 0.54 (0.34 to 0.81)
Alcohol consumption – – – – 
  Never – – – 1 (ref)
  1–2 drinks a day – – – 0.98 (0.77 to 1.26)
  ≥3 drinks a day – – – 1.25 (0.92 to 1.70)
Education level – – – – 
  No graduation – – – 1 (ref)
  No HSD – – – 0.76 (0.51 to 1.16)
  ≥HSD – – – 0.93 (0.64 to 1.39)
Baecke’s score – – – 0.99 (0.94 to 1.04)
Living alone – – – 0.87 (0.73 to 1.04)
Diabetes – – – 0.95 (0.63 to 1.39)
Hypertension – – – 0.93 (0.79 to 1.09)
Prevalent CVD – – – 1.63 (1.01 to 2.56)
Use of sleep medication – – – 0.95 (0.65 to 1.32)
Night working – – – 0.90 (0.46 to 1.63)
Proxy for ethnicity, n (%) – – – 
  Caucasian – – – 1 (ref)
  African – – – 0.87 (0.68 to 1.11)
  Non-Caucasian, non-
African
– – – 1.13 (0.75 to 1.65)
 Model 1 is adjusted for age and sex, model 2: model 1+depression, model 3: model 2+sleep duration, model 4: model 3+all covariates listed 
in the table.
CVD, cardiovascular disease; HSD, high school diploma; Ref, reference category.
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the adult body silhouettes and EDS. Similarly, BMI at 
study recruitment did not impact the association between 
‘lean-marked increase’ and ‘heavy-stable’ body silhouette 
trajectories and EDS. This indicates that the body silhou-
ette lifetime approach provides information on the like-
lihood of EDS in adulthood beyond the one given by the 
last body silhouette or BMI.
Furthermore, the extent to which our study results 
reflect the effect of body silhouette trajectory per se or the 
effect of confounding factors associated with a pattern of 
body silhouette trajectory is a challenging issue. Psycho-
logical factors should be considered in this context.2 13 
However, despite the strong association between depres-
sive symptoms and EDS, the relationship between body 
silhouette trajectory and EDS remained after adjusting for 
depressive symptoms. Also, the extent to which our study 
results reflect the effect of body silhouette trajectory on 
EDS or on related sleep disorders or sleep patterns that 
correlate with EDS deserve to be studied. In our study, 
associations between EDS and body silhouette trajectories 
were still present after adjustment for sleep duration and 
for a proxy for SDB, and despite the associations between 
EDS and these two sleep variables.
Clinical implications
Given the prevalence of EDS and its deleterious conse-
quences on a wide spectrum of health-related outcomes, 
identifying modifiable determinants is of public health 
importance. Our study results suggest that body silhou-
ette trajectory may bring information beyond BMI or 
waist circumference. Therefore, in addition to these 
two anthropometric measurements, body silhouette 
trajectories could be easily performed during an office-
based consultation to identify subjects at increased risk 
of several medical conditions, including EDS. From our 
study results, it appears that such evaluation should start 
early in childhood. In addition to screening and inter-
vening on depression, sleep duration and SDB, which 
have shown here and in other studies to be determi-
nants of EDS, subjects constantly gaining weight may 
be proposed weight reduction programmes even in the 
absence of obesity.12
study limitations
Despite the size of our study, the consideration of both 
men and women, and the use of a standardised tool to 
define subjective EDS, we acknowledge the following 
limitations. First, we relied on self-reported body silhou-
ettes and not on objectively measured anthropometric 
markers. However, self-reported body silhouettes are well 
correlated with objective measures of BMI.18 19 Second, 
body silhouettes at different age periods were not evalu-
ated prospectively but retrospectively at study recruitment 
when participants were adult. However, recall of body 
silhouette at different ages correlates well with objective 
BMI measurements at the corresponding ages.18 Third, 
the last body silhouette refers to age 45, while age at study 
entry ranged from 50 to 75. However, body silhouette 
trajectories were not influenced by age at study entry in 
our study. Fourth, the modelling of trajectories being 
cohort dependent, our results may not be appropriate in 
other populations. Nevertheless, the trajectories found in 
our study are very similar to trajectories obtained in other 
studies.20 23 Fifth, we had no objective polysomnograph-
ical records to estimate night sleep duration or the pres-
ence of a SDB, and instead used self-reported night sleep 
duration and a proxy for SDB.
In summary, in this community-based cohort, increasing 
and constantly high body silhouette trajectories from 
childhood to adulthood were associated with increased 
likelihood of EDS, independently of major confounding 
variables. This trajectory approach allowed us to identify 
new clusters of subjects at risk of EDS, independently of 
BMI, sleep duration and proxy for SDB.
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